EZH2 suppression in glioblastoma shifts microglia toward M1 phenotype in tumor microenvironment

Abstract

Our data demonstrates that EZH2 participates in GBM-induced immune deficient and EZH2 suppression in GBM can remodel microglia immune functions, which is beneficial for understanding GBM pathogenesis and suggests potential targets for therapeutic approaches.